Meghan G. Thomas

1.1k total citations
34 papers, 874 citations indexed

About

Meghan G. Thomas is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Meghan G. Thomas has authored 34 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 14 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Meghan G. Thomas's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Pluripotent Stem Cells Research (7 papers) and Neurological disorders and treatments (5 papers). Meghan G. Thomas is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Pluripotent Stem Cells Research (7 papers) and Neurological disorders and treatments (5 papers). Meghan G. Thomas collaborates with scholars based in Australia, United Kingdom and United States. Meghan G. Thomas's co-authors include Romola S. Bucks, Andrea M. Loftus, Wei Dong Le, Robert B. White, Kate Cruise, Mel Ziman, Robert U. Newton, Roger A. Barker, Natalie Gasson and Christopher R. P. Lind and has published in prestigious journals such as PLoS ONE, Experimental Brain Research and Experimental Cell Research.

In The Last Decade

Meghan G. Thomas

34 papers receiving 860 citations

Peers

Countries citing papers authored by Meghan G. Thomas

Since Specialization

Citations

This map shows the geographic impact of Meghan G. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan G. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan G. Thomas more than expected).

Fields of papers citing papers by Meghan G. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan G. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan G. Thomas. The network helps show where Meghan G. Thomas may publish in the future.

Co-authorship network of co-authors of Meghan G. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan G. Thomas. A scholar is included among the top collaborators of Meghan G. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan G. Thomas. Meghan G. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beyond factor analysis: Multidimensionality and the Parkinson’s Disease Sleep Scale-Revised 2018 ·PLoS ONE ·(unknown), Andrea M. Loftus, Natalie Gasson, Meghan G. Thomas, (unknown), Michelle Olaithe, Romola S. Bucks	5
2	Developmental transcription factors in age-related CNS disease: a phoenix rising from the ashes? 2016 ·Australasian Journal of Paramedicine ·Robert B. White, Meghan G. Thomas	2
3	PAX6 expression may be protective against dopaminergic cell loss in Parkinson's disease 2016 ·CNS & Neurological Disorders - Drug Targets ·Meghan G. Thomas, (unknown), (unknown), (unknown), Roger A. Barker, Robert B. White	15
4	Motor Subtype as a Predictor of Future Working Memory Performance in Idiopathic Parkinson's Disease 2016 ·PLoS ONE ·Andrew R. Johnson, Romola S. Bucks, Robert Kane, Meghan G. Thomas, Natalie Gasson, Andrea M. Loftus	10
5	Suitability of the Depression, Anxiety, and Stress Scale in Parkinson’s Disease 2016 ·Journal of Parkinson s Disease ·Andrew R. Johnson, Blake J. Lawrence, (unknown), Leon Booth, Natalie Gasson, Meghan G. Thomas, Andrea M. Loftus, Romola S. Bucks	14
6	Retrospective Assessment of Movement Disorder Society Criteria for Mild Cognitive Impairment in Parkinson’s Disease 2015 ·Journal of the International Neuropsychological Society ·Andrea M. Loftus, Romola S. Bucks, Meghan G. Thomas, Robert Kane, (unknown), Roger A. Barker, Natalie Gasson	15
7	The relationship between sleep and cognition in Parkinson's disease: A meta-analysis 2015 ·Sleep Medicine Reviews ·(unknown), Andrea M. Loftus, Meghan G. Thomas, Natalie Gasson, Romola S. Bucks	42
8	The Impact of Dementia Development Concurrent with Parkinson’s Disease: A New Perspective 2014 ·CNS & Neurological Disorders - Drug Targets ·Alyce Russell, (unknown), Wei Wang, Meghan G. Thomas	18
9	Personality Affects Aspects of Health-Related Quality of Life in Parkinson's Disease via Psychological Coping Strategies 2013 ·Journal of Parkinson s Disease ·(unknown), Andrea M. Loftus, Timothy Skinner, Natalie Gasson, Roger A. Barker, Romola S. Bucks, Meghan G. Thomas	36
10	Moving Beyond Tyrosine Hydroxylase to Define Dopaminergic Neurons for Use in Cell Replacement Therapies for Parkinson’s Disease 2012 ·CNS & Neurological Disorders - Drug Targets ·Robert B. White, Meghan G. Thomas	47
11	Neurosurgical convection-enhanced delivery of treatments for Parkinson’s disease 2011 ·Journal of Clinical Neuroscience ·(unknown), Meghan G. Thomas, Christopher R. P. Lind	23
12	Exercise and Parkinson’s: benefits for cognition and quality of life 2010 ·Acta Neurologica Scandinavica ·Kate Cruise, Romola S. Bucks, Andrea M. Loftus, Robert U. Newton, (unknown), Meghan G. Thomas	161
13	Bone marrow stromal cells as replacement cells for Parkinson’s disease: generation of an anatomical but not functional neuronal phenotype 2010 ·Translational research ·Meghan G. Thomas, (unknown), (unknown), (unknown), Mel Ziman, Livia C. Hool	22
14	Coping processes and health‐related quality of life in Parkinson's disease 2010 ·International Journal of Geriatric Psychiatry ·Romola S. Bucks, Kate Cruise, Timothy Skinner, Andrea M. Loftus, Roger A. Barker, Meghan G. Thomas	57
15	Graft outcomes influenced by co‐expression of Pax7 in graft and host tissue 2009 ·Journal of Anatomy ·Meghan G. Thomas, Pam Tyers, Stanley E. Lazic, Roger A. Barker, (unknown), Mel Ziman	4
16	Pax7 expression in the adult rat superior colliculus following optic nerve injury 2007 ·Neuroreport ·Meghan G. Thomas, Roger A. Barker, L.D. Beazley, Mel Ziman	9
17	A multiphasic role for Pax7 in tectal development 2006 ·Experimental Brain Research ·Meghan G. Thomas, Lyn Beazley, Mel Ziman	11
18	Minocycline: Neuroprotective Mechanisms in Parkinsons Disease 2004 ·Current Pharmaceutical Design ·Meghan G. Thomas, Wei Dong Le	85
19	Expression profiles suggest a role for Pax7 in the establishment of tectal polarity and map refinement 2004 ·Experimental Brain Research ·Meghan G. Thomas, (unknown), Lyn Beazley, Mel Ziman	17
20	A Key Role for Pax7 Transcripts in Determination of Muscle and Nerve Cells 2001 ·Experimental Cell Research ·Mel Ziman, Meghan G. Thomas, P.F. Jacobsen, Lyn Beazley	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact